Bright Horizons (BFAM) PT Raised to $77 at Morgan Stanley

Morgan Stanley analyst Toni Kaplan raised the price target on Bright Horizons (NYSE: BFAM) to $77.00 (from $75.00) while maintaining a Underweight rating.

The analyst comments "Strong 4Q beat across all metrics with guidance above on revenue, but slightly below on EPS. We expect investors to focus on profitability in '24 as revenue normalizes and ARPA funding has expired. We are 7% below the guidance midpt on '24 EPS. BFAM remains our highest conviction UW, PT to $77."

You May Also Be Interested In

• Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
• Freedom Broker Downgrades Nucor (NUE) to Hold, 'Guides Conservative Earnings Yet Again'
• Envista Holdings Corp. (NVST) PT Lowered to $27 at UBS, Neutral Rating Maintained